Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. (RCKT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RCKT · as of Jun 9, 2026
Key Statistics
Explore Rocket Pharmaceuticals, Inc. Data
rckt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 68.4%
The RCKT analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +85.19% upside from the current price of $2.70.
Competitors & Peers
rckt competitorsRCKT
ANNX
AURA
AUTL
DBVT
DSGNStock Performance
Full HistoryAbout Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The comp…
what is rocket pharmaceuticals, inc. · rckt stock overview · rocket pharmaceuticals, inc. company profile · who is rocket pharmaceuticals, inc. ceo · rckt NASDAQ · rocket pharmaceuticals, inc. headquarters · rocket pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Rocket Pharmaceuticals, Inc. (RCKT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 18, 2015. As of the latest trading session, RCKT stock price is $2.70, with a market capitalization of $294.8M. The stock has returned -11.16% over the past 12 months and -23.56% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Rocket Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Rocket Pharmaceuticals, Inc. reported revenue of — and net income of -$223.1M. For detailed data — including Rocket Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rocket Pharmaceuticals, Inc. (RCKT) stock price is $2.70. The stock is traded on NASDAQ under the ticker symbol RCKT. The 52-week range is $2.40 – $5.45.